Overview

The Michigan Institute for Clinical & Health Research (MICHR) is leading the way in building the field of translational science, with the intent of extending life and reducing the impact of illness and disability.

MICHR is developing and demonstrating scientific and operational innovations in the translational process, shortening the time to develop and deliver new treatments, and then sharing these solutions nationally.

We are proud to be part of the national NCATS CTSA Program, with more than 60 academic research institutes working together to improve the process of translational research to deliver more treatments to more patients more quickly.

History

Founded in 2006, MICHR received a Clinical and Translational Science Award in 2007 from the National Institutes of Health (NIH). Renewed in 2012, 2017, and 2023, MICHR is part of a national consortium of more than 60 academic research institutions funded by the CTSA program, accelerating discoveries toward better health.

Cite It

Please help us continue our support for clinical and translational research by citing our grant number in relevant publications: UM1TR004404.